Back To: Home : Resources : White Papers




July 23-25, 2013
Tumor Models - Bostom MA

October 22-26, 2013
ASHG - Bostom, Ma

More Events
Name:
Company:
Email:
 
 
 
PerkinElmer

White Papers
 
                 
Company
White Paper
Eppendorf
 
  
SDIX®
 
 
 
Mirus Bio, LLC 
 
Singulex 
 
Hamilton Company
 
Applied Photophysics Ltd
 
Waters
 
 
 
AMRI
 

 
Waters Corp.
 
Gilson, Inc

Analyzing catecholamines and their metabolites in patient urine samples is important for sympathoadrenal system tumor diagnosis. This application note discusses the automation of sample preparation and solid phase extraction (SPE) with the CIinRep Complete Kit (RECIPE Chemicals + Instruments GmbH) using the Gilson ASPECTMXL or GX-274 Liquid Handler. Following SPE, fractions were analyzed via HPLC for analytes VMA, HVA, and 5-HIAA using an electrochemical detection (ECD) method.


Applied Photophysics Ltd
INDIGO Biosciences, Inc.
Bio-Rad Laboratories
 
Shimadzu Scientific Instruments 
Gilson, Inc
Bio-Rad Laboratories
 
Applied Photophysics Ltd  
Strategies to compare far-UV Circular Dichroism spectra of similar proteins using Chirascan™-plus ACD  
 
Circular Dichroism (CD) spectroscopy is an extremely sensitive technique to analyse the conformation of proteins in solution and can be used as a fingerprint of a particular protein structure [Greenfield, 2006]. Due to the very low sample volumes required and the simplicity of the measurement, it is a powerful comparative tool to detect differences in structure between proteins.
 
This paper discusses how Chirascan™-plus ACD presents easy-to-obtain, highly reproducible results while achieving high throughput, previously not available for Circular Dichroism. Using advanced robotics combined with the 96 or 384-well plates, Chirascan™-plus ACD can rapidly prepare many replicates and perform multiple measurements for clear determination of standard deviations.
BIOSEARCH TECHNOLOGIES
InhibOx
JMP Clinical

A Primer on JMP® Clinical Incidence Screens

JMP Clinical has a number of analytical processes (APs) that calculate and compare the incidence of events between two or more treatment groups in a clinical trial. Interventions Incidence Screen enables you to compare the incidence of concomitant medications or substances. AE Incidence Screen enables you to compare the incidence of adverse events. DS/MH Incidence Screen enables you to compare disposition events (e.g., randomization or completion status) or medical history terms (which, technically, is a comparison of prevalence). Finally, AE Resolution Screen enables you to examine the resolution of adverse events. Most of these APs operate in a similar manner. In this white paper, we use AE Incidence Screen with sample data to illustrate the common functionality of these APs. We also point out important differences among the other APs at the end of the example

Lucigen Corporation
EMD Millipore
Profiling of putative lead compounds against a representative panel of important enzymes, receptors, ion channels and transporters is an excellent way to establish a preliminary view of potential issues that might later hamper development. An early idea of which off-target activities must be minimized can save valuable time and money during the preclinical lead optimization phase if pivotal questions are asked beyond the usual profiling at hERG. The best data for critical evaluation of activity at GPCRs and ion channels is obtained using functional assays, since binding assays cannot detect all interactions and do not provide information on whether the interaction is that of an agonist, antagonist, or allosteric modulator. This overview discusses the benefits of in vitro assays, specific decision points where profiling can be of immediate benefit, and highlights relevant profiling services offered by EMD Millipore. 
DiscoveRX
INDIGO Biosciences
SABiosciences, a QIAGEN company
Trevigen, Inc
DiscoveRX

Caliper Life Sciences 

Caliper Discovery Alliances & Services

 

Ariadne Genomics
Gilson, Inc
SABiosciences, a QIAGEN company
Accuri Cytometers, Inc.
MD Biosciences, Inc
Invitrogen by Life Technologies
Accuri Cytometers, Inc.
BioTek Instruments, Inc.
Invitrogen by Life Technologies
SABiosciences
R&D Systems, Inc.
Millipore
R&D Systems, Inc.
Trevigen, Inc.
SANYO Biomedical

Caliper Life Sciences

The Baker Company
Back West, Inc. and Jumpstart Biodevelopment

AstraZeneca LP

Adeptia Inc.


PerkinElmer

Gilson


Asuragen

Eppendorf

INDIGO

BioTek
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2013 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.